Find a Tender
complete
Official procurement procedure
Proton range verification detectors
Detection apparatus
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The Christie NHS Foundation Trust: "Proton range verification detectors". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | The Christie NHS Foundation Trust | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: The Christie NHS Foundation Trust
Market Analytics
Derived from OCDS awards & bid statistics
Published history for The Christie NHS Foundation Trust. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
2.7Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 6 active published awards; 6 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityThe Christie NHS Foundation Trust | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published1 Jun 2022, 15:01 BST | Last source update1 Jun 2022, 15:01 BST | Recurring procurementNot published |
ClassificationDetection apparatus | ||
Delivery area | ||
OCIDocds-h6vhtk-030de2 | ||
What is being bought
The PRECISE proton therapy research group at the University of Manchester and the Christie NHS Foundation Trust is developing a system to verify range during proton beam therapy treatments. Range uncertainty is arguably one of the biggest challenges in proton therapy. Range uncertainty arises from a number of sources: imaging, dosimetry, stopping powers, however, the largest uncertainty is always the patient. Patient setup, highly heterogeneous tissue, implants, or bone/tissue interfaces as well as anatomical changes during treatment can all influence proton range and thus, treatment outcomes. The full potential of proton beam therapy, particularly when there are organs-at-risk in the vicinity of the tumour, cannot be exploited unless these uncertainties are reduced or mitigated.
One possible method of determining proton range is through the detection of the prompt gamma-rays that are emitted naturally during therapy. It has been shown experimentally that the maximum intensity of these prompt gamma rays correlates well with the Bragg peak and end-of-range. By detecting these prompt gamma-rays and determining their origin the proton beam range could be established.
The system being developed is based on an array of scintillator detectors coupled with an image reconstruction algorithm based on gamma-ray coincidences. The detectors of choice are LaBr3 scintillators which exhibit good energy and timing resolution for the detection of the high energy gamma-rays emitted. The typical gamma-ray energy range of interest is 2 – 8 MeV so large crystal, 38.1 mm (1.5”) diameter and 50.8 mm (2”) long, detectors are required in order to obtain full energy photo peaks. As the reconstruction algorithm utilises gamma-ray coincidences, the detectors need to have an energy resolution of 3.5% or less at 662 keV and a coincidence resolving time of 0.5 ns or less. Ideally we are also looking for the detectors to have an anode pulse rise time of 0.8 ns or less and an electron transit time of 16 ns or less.
What changed
From the official release history
- tender value changed
1 Jun 2022, 15:01 BST - Status changed to complete
1 Jun 2022, 15:01 BST - Official notice release published
1 Jun 2022, 15:01 BST - Submission deadline changed to published date
1 Jun 2022, 15:01 BST - Published value updated to £130,000
21 Jan 2022, 14:15 GMT - Status changed to active
21 Jan 2022, 14:15 GMT - Official notice release published
21 Jan 2022, 14:15 GMT - Submission deadline changed to 24 Feb 2022, 16:00 GMT
21 Jan 2022, 14:15 GMT - Buyer information updated
21 Jan 2022, 14:15 GMT
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcancelledPublished valueNot publishedThe PRECISE proton therapy research group at the University of Manchester and the Christie NHS Foundation Trust is developing a system to verify range during proton beam therapy treatments. Range uncertainty is arguably one of the biggest challenges in proton therapy. Range uncertainty arises from a number of sources: imaging, dosimetry, stopping powers, however, the largest uncertainty is always the patient. Patient setup, highly heterogeneous tissue, implants, or bone/tissue interfaces as well as anatomical changes during treatment can all influence proton range and thus, treatment outcomes. The full potential of proton beam therapy, particularly when there are organs-at-risk in the vicinity of the tumour, cannot be exploited unless these uncertainties are reduced or mitigated. One possible method of determining proton range is through the detection of the prompt gamma-rays that are emitted naturally during therapy. It has been shown experimentally that the maximum intensity of these prompt gamma rays correlates well with the Bragg peak and end-of-range. By detecting these prompt gamma-rays and determining their origin the proton beam range could be established. The system being developed is based on an array of scintillator detectors coupled with an image reconstruction algorithm based on gamma-ray coincidences. The detectors of choice are LaBr3 scintillators which exhibit good energy and timing resolution for the detection of the high energy gamma-rays emitted. The typical gamma-ray energy range of interest is 2 – 8 MeV so large crystal, 38.1 mm (1.5”) diameter and 50.8 mm (2”) long, detectors are required in order to obtain full energy photo peaks. As the reconstruction algorithm utilises gamma-ray coincidences, the detectors need to have an energy resolution of 3.5% or less at 662 keV and a coincidence resolving time of 0.5 ns or less. Ideally we are also looking for the detectors to have an anode pulse rise time of 0.8 ns or less and an electron transit time of 16 ns or less.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
1 Jun 2022, 15:01 BST - Award active
Not published · Not published - Contract active
Signed 24 May 2022, 00:00 BST · £120,290
Commercial outcome and competition
Awards Mi-Net Technology Ltt Not published · Not published · active |
Contracts Contract £120,290 · signed 24 May 2022, 00:00 BST · active |
Bid statistics bids: 2 (lot 1) electronicBids: 2 (lot 1) foreignBidsFromEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) smeBids: 2 (lot 1) |
Buyer and organisations in this procedure
The Christie NHS Foundation Trust
Contracting authority GB-FTS-35200Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published